In 2019 Legion Healthcare Partners was formed by John Styles, Jr. and Matt Palmer. Legion was founded with one mission—to take on the fight against cancer. The goal of Legion is to provide solutions which eliminate the barriers to entry for proton therapy development and ownership.

Previously, Mr. Styles and Mr. Palmer formed a public/private partnership with The University of Texas MD Anderson Cancer Center to develop, own and operate a proton therapy center (Proton Therapy Center-Houston Ltd. LLP), serving as the General Partner and C-Level employees of the joint venture. Mr. Styles served as a Managing Member of the General Partner and Chief Executive Officer and Mr. Palmer as Chief Operating Officer. Our strategic vision was to define the benefits and value of proton therapy, both clinically and economically.

In addition to increasing access to the technology for domestic and international patients, our team was responsible for the ownership structure, commercial structure, legal formation, financing, development and operational management of the five room proton therapy facility.

Over a period of 13 years, PTC-H treated in excess of 11,000 cancer patients from around the world. Our team was the first to clinically develop pencil beam scanning and intensity‐modulated proton therapy (IMPT). Due to increased utilization of proton therapy, IMPT capacity limitations, and the operational success of the existing proton therapy center, in 2014 the
PTC-H management team began its work and due diligence to provide the largest expansion of proton therapy in the United States. We successfully raised $120 million, developed the proton therapy technical specifications and building design for the additional four scanning rooms needed in the expansion. In November 2018 we sold our interest to MD Anderson.